UCB partnered with OXO Good Grips® to design a prefilled syringe
for patients who are capable of self-administration.
Patients who are capable may self-inject CIMZIA using the prefilled syringe, after
proper training in subcutaneous injection and if a physician determines that it
Patients using CIMZIA should be instructed to inject the full amount in the syringe,
200 mg (1 mL), according to the directions provided in the "Patient Instructions
for Use" booklet found in each Cimzia Prefilled Syringe kit.
UCB, the manufacturer of CIMZIA, partnered with OXO Good Grips to
develop a syringe that would be easy to grip, and the result is a prefilled syringe designed with RA patients in mind.1
In an observational usability study* to examine how people living with RA grip and
hold a syringe, 74% of RA patients said they would prefer a syringe designed to1:
*Usability study was conducted in 23 RA patients with varying degrees of disease
severity to assess 19 attributes of an existing prefilled syringe versus a prefilled
syringe variant developed by OXO®.2
NEXT: How to Use the CIMZIA
Prefilled Syringe »
CIMZIA is indicated for the treatment of adults with moderate to severe rheumatoid
Important Safety Information
Serious and sometimes fatal side effects have been reported with CIMZIA, including tuberculosis (TB), bacterial sepsis, invasive fungal infections (such as histoplasmosis), and infections due to other opportunistic pathogens (such as Legionella or Listeria). Patients should be closely monitored for the signs and symptoms of infection during and after treatment with CIMZIA. Lymphoma and other malignancies, some fatal, have been reported in children and adolescent patients treated with TNF blockers, of which CIMZIA is a member. CIMZIA is not indicated for use in pediatric patients
*Not valid for prescriptions that are reimbursed, in whole or part, under Medicare (including Medicare Part D), Medicaid, similar federal or state funded programs (including any state prescription drug assistance programs and the Government Health Insurance Plan available in Puerto Rico) or where otherwise prohibited by law. Product dispensed pursuant to program rules and federal and state laws. Claims should not be submitted to any public payor (i.e., Medicare, Medicaid, Medigap, Tricare, VA and DoD) for reimbursement. Patients and pharmacists are responsible for notifying insurance carriers or other third party who pays for or reimburses any part of the prescription filled using this card as may be required by the insurance carrier's terms and conditions and applicable law. The parties reserve the right to amend or end this program at any time without notice.
For more information 1-866-4-CIMZIA (1-866-424-6942)
For U.S. Healthcare Professionals
UCB, Inc. All rights reserved.
CIMZIA® and CIMplicity®
are trademarks of the UCB Group of Companies.
OXO Good Grips® and the associated logos are trademarks of Helen of Troy Limited
and are used under license.